| Stage | CHRW | % of rev | EME | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.4B | 100.00% | $5.5B | 100.00% | EME ×1.03 |
| Gross profit | $448M | 8.36% | $1.1B | 20.00% | EME +11.6pp |
| Operating income | $272M | 5.07% | $546M | 9.85% | EME +4.8pp |
| Pre-tax income | $250M | 4.67% | $550M | 9.92% | EME +5.2pp |
| Net income | $198M | 3.70% | $400M | 7.22% | EME +3.5pp |
| Stage | CHRW | EME | Gap · A − B |
|---|---|---|---|
| Revenue | $5.4B100.00% | $5.5B100.00% | EME ×1.03 |
| Gross profit | 8.36%$448M | 20.00%$1.1B | EME +11.6pp |
| Operating income | 5.07%$272M | 9.85%$546M | EME +4.8pp |
| Pre-tax income | 4.67%$250M | 9.92%$550M | EME +5.2pp |
| Net income |
| 3.70%$198M |
| 7.22%$400M |
| EME +3.5pp |
No disclosed counterparties: CHRW, EME.